Abstract 1442: Targeting ATM kinase and mTOR signaling reverses bone marrow stromal cell-mediated protection of FLT3-ITD AML from FLT3-targeted therapy

Author(s):  
Hae J. Park ◽  
Mark A. Gregory ◽  
Vadym Zaberezhnyy ◽  
James DeGregori
2012 ◽  
Vol 41 (4) ◽  
pp. 437-442 ◽  
Author(s):  
Hidetaka Nishida ◽  
Masanari Nakayama ◽  
Hiroshi Tanaka ◽  
Masahiko Kitamura ◽  
Shingo Hatoya ◽  
...  

Biomaterials ◽  
2013 ◽  
Vol 34 (10) ◽  
pp. 2389-2398 ◽  
Author(s):  
Wojtek Tutak ◽  
Sumona Sarkar ◽  
Sheng Lin-Gibson ◽  
Tanya M. Farooque ◽  
Giri Jyotsnendu ◽  
...  

PLoS ONE ◽  
2010 ◽  
Vol 5 (3) ◽  
pp. e9690 ◽  
Author(s):  
Fariba Rezaee ◽  
Stephanie L. Rellick ◽  
Giovanni Piedimonte ◽  
Stephen M. Akers ◽  
Heather A. O'Leary ◽  
...  

2015 ◽  
Vol 34 (1) ◽  
pp. 154-160 ◽  
Author(s):  
Chunfeng Zhao ◽  
Yasuhiro Ozasa ◽  
Haruhiko Shimura ◽  
Ramona L. Reisdorf ◽  
Andrew R. Thoreson ◽  
...  

Cell ◽  
1987 ◽  
Vol 48 (6) ◽  
pp. 1009-1021 ◽  
Author(s):  
Cheryl A. Whitlock ◽  
George F. Tidmarsh ◽  
Christa Muller-Sieburg ◽  
Irving L. Weissman

1992 ◽  
Vol 51 (S1) ◽  
pp. S16-S20 ◽  
Author(s):  
Kohei Notoya ◽  
Ryoichi Tsukuda ◽  
Keiji Yoshida ◽  
Shigehisa Taketomi

2010 ◽  
Vol 16 (6) ◽  
pp. 1913-1923 ◽  
Author(s):  
John T. Connelly ◽  
Eric J. Vanderploeg ◽  
Janna K. Mouw ◽  
Christopher G. Wilson ◽  
Marc E. Levenston

2018 ◽  
Vol 82 ◽  
pp. 1-11 ◽  
Author(s):  
Melanie J. Gupte ◽  
W. Benton Swanson ◽  
Jiang Hu ◽  
Xiaobing Jin ◽  
Haiyun Ma ◽  
...  

Blood ◽  
1989 ◽  
Vol 74 (3) ◽  
pp. 1144-1151
Author(s):  
P Anklesaria ◽  
TJ FitzGerald ◽  
K Kase ◽  
A Ohara ◽  
JS Greenberger

The ability of a clonal hematopoiesis-supportive bone-marrow stromal cell line GBlneor to engraft and alter the microenvironment-induced anemia of Sl/Sld mice was studied. Prior to stromal cell transplantation, Sl/Sld mice received 1 Gy total body irradiation (TBI) and 13 Gy to the right hind limb. Two months after intravenous (IV) injection of 5 x 10(5) GBlneor cells, 54.4% +/- 17.0% donor origin (G418r) colony-forming cells were recovered from the right hind limb of Sl/Sld mice. Long-term bone marrow cultures (LTBMCs) established from GBlneor-transplanted mice produced 189.5 CFU-GEMM-forming progenitors/flask over 10 weeks compared with 52.7 +/- 6.2 CFU-GEMM forming progenitors/flask from irradiated nontransplanted Sl/Sld mice. A partial correction of macrocytic anemia was detected 2 months after GBlneor transplantation in splenectomized, irradiated Sl/Sld mice (HgB 7.2 +/- 0.4 g/dL; MCV 68.3 +/- 7.0 fL) compared to splenectomized, irradiated, nontransplanted Sl/Sld mice (HgB 5.5 +/- 1.1 g/dL; MCV 76 +/- 8.5 fL) or control Sl/Sld mice (HgB 5.4 +/- 0.5 g/dL; MCV 82.4 +/- 1.3 fL). Mean RBC volume distribution analysis showed a 2.5-fold increase in percentage of peripheral blood RBCs with MCV less than or equal to 45 fL and confirmed reduction of the MCV in splenectomized- GBlneor-transplanted mice compared to control Sl/Sld mice. A hematopoiesis-suppressive clonal stromal cell line derived from LTBMCs of Sl/Sld mice (Sldneor) engrafted as effectively (43.5% +/- 1.2% G418r CFU-F/limb) as did GBlneor cells (38.3% +/- 0.16% G418r CFU-F/limb) to the irradiated right hind limbs of C57Bl/6 mice. LTBMCs established after 2 or 6 months from Sldneor-transplanted mice showed decreased hematopoiesis (182 +/- 12 [2 months] and 3494.3 +/- 408.1 [6 months] CFU-GEMM forming progenitors/flask over 10 weeks) compared to those established from GBlneor-transplanted mice (5980 +/- 530 [2 months] and 7728 +/- 607, [6 months] CFU-GEMM progenitors forming/flask). Thus, transplantation of clonal bone-marrow stromal cell lines in vivo can stably transfer their physiologic properties to normal or mutant mice.


Sign in / Sign up

Export Citation Format

Share Document